A CASE SERIES OF SUCCESSFUL OFF-LABEL USE OF FLIBANSERIN

被引：0
|
作者：
Trowbridge, P. [1 ]
Padhye, M. [2 ]
Rubin, R. [3 ]
机构：
[1] Rush Univ, Rush Med Coll, Chicago, IL USA
[2] Rosalind Franklin Univ, Chicago Med Sch, Chicago, IL USA
[3] Georgetown Univ Hosp, Washington, DC USA
来源：
JOURNAL OF SEXUAL MEDICINE | 2023年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
423
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The successful off-label use of photodynamic therapy for classic porokeratosis of Mibelli: case report
    Giuliodori, Katia
    Campanati, Anna
    Ganzetti, Giulia
    Conocchiari, Luca
    Cataldi, Ivana
    Simonetti, Oriana
    Giangiacomi, Mirella
    Offidani, Annamaria
    DERMATOLOGIC THERAPY, 2011, 24 (05) : 501 - 504
  • [22] Off-label use in cardiac surgery ["Off-label use" in der Herzchirurgie]
    Fenger H.
    Löher A.
    Sindermann J.R.
    Scheld H.H.
    Schmidt C.
    Hoffmeier A.
    Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, 2009, 23 (6) : 345 - 348
  • [23] Off-Label Use of Sirolimus and Everolimus in a Pediatric Center: A Case Series and Review of the Literature
    M. Bevacqua
    F. Baldo
    S. Pastore
    E. Valencic
    Alberto Tommasini
    A. Maestro
    M. Rabusin
    A. Arbo
    E. Barbi
    Pediatric Drugs, 2019, 21 : 185 - 193
  • [24] Off-label Use of Memantine as Adjunctive Treatment in Schizophrenia: A Retrospective Case Series Study
    John, J. P.
    Lukose, A.
    Manjunath, S.
    PHARMACOPSYCHIATRY, 2014, 47 (06) : 202 - 209
  • [25] Off-Label Use of Sirolimus and Everolimus in a Pediatric Center: A Case Series and Review of the Literature
    Bevacqua, M.
    Baldo, F.
    Pastore, S.
    Valencic, E.
    Tommasini, Alberto
    Maestro, A.
    Rabusin, M.
    Arbo, A.
    Barbi, E.
    PEDIATRIC DRUGS, 2019, 21 (03) : 185 - 193
  • [26] Off-label use and G-BA. Legal framework for off-label use
    Brucklacher, U.
    Brockmeyer, N. H.
    Riedel, C.
    HAUTARZT, 2013, 64 (10): : 736 - 742
  • [27] Mirtazapine/pregabalinDelirium and off-label use: case report
    Reactions Weekly, 2024, 2029 (1) : 384 - 384
  • [28] DexamethasoneHyperglycaemia following off-label use: case report
    Reactions Weekly, 2022, 1896 (1) : 173 - 173
  • [29] FavipiravirNephrotoxicity following off-label use: case report
    Reactions Weekly, 2022, 1929 (1) : 283 - 283
  • [30] BevacizumabRetinal breaks and off-label use: case report
    Reactions Weekly, 2022, 1924 (1) : 120 - 120
12345